APOA2 and metabolic disease: In addition, increased apoA-II was found in patients with endocrine-metabolic diseases, as compared to non-endocrine-metabolic diseases individuals, while no difference was found in apoA-II when patients with cardiovascular disease were compared with non-cardiovascular disease individuals [136].